195 related articles for article (PubMed ID: 37746430)
1. Antisynthetase Syndrome With Predominant Pulmonary Involvement: A Case Report.
Lima Corrêa de Araújo B; Victor DR; Farias Fontes HM; Caminha Mendes Gomes RM; Lima Corrêa de Araújo L
Cureus; 2023 Aug; 15(8):e43966. PubMed ID: 37746430
[TBL] [Abstract][Full Text] [Related]
2. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
[TBL] [Abstract][Full Text] [Related]
4. Review of Pulmonary Manifestations in Antisynthetase Syndrome.
Ghanbar MI; Danoff SK
Semin Respir Crit Care Med; 2024 Jun; 45(3):365-385. PubMed ID: 38710221
[TBL] [Abstract][Full Text] [Related]
5. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
Patel P; Marinock JM; Ajmeri A; Brent LH
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674039
[TBL] [Abstract][Full Text] [Related]
6. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
[TBL] [Abstract][Full Text] [Related]
7. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
8. Antisynthetase Syndrome: The Classical Phenotype With a Twist.
Betsikos A; Gazouni E; Bika S; Paschou E; Sabanis N
Cureus; 2023 Jul; 15(7):e42360. PubMed ID: 37621814
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and treatment of antisynthetase syndrome.
Marco JL; Collins BF
Best Pract Res Clin Rheumatol; 2020 Aug; 34(4):101503. PubMed ID: 32284267
[TBL] [Abstract][Full Text] [Related]
10. [Antisynthetase syndromes].
Bauhammer J; Fiehn C
Z Rheumatol; 2019 Sep; 78(7):645-655. PubMed ID: 31346706
[TBL] [Abstract][Full Text] [Related]
11. ["Mechanic's hands" during antisynthetase syndrome: a marker of systemic involvement?].
Nahas O; Haddad F; Maalouly G
Ann Dermatol Venereol; 2015 Mar; 142(3):189-92. PubMed ID: 25620556
[TBL] [Abstract][Full Text] [Related]
12. Myositis-related interstitial lung disease and antisynthetase syndrome.
Solomon J; Swigris JJ; Brown KK
J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438
[TBL] [Abstract][Full Text] [Related]
13. [Acute interstitial lung disease revealing antisynthetase syndrome].
Bizien N; Renault A; Boles JM; Delluc A
Rev Pneumol Clin; 2011 Dec; 67(6):367-70. PubMed ID: 22137282
[TBL] [Abstract][Full Text] [Related]
14. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
15. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
Pinal-Fernandez I; Casal-Dominguez M; Huapaya JA; Albayda J; Paik JJ; Johnson C; Silhan L; Christopher-Stine L; Mammen AL; Danoff SK
Rheumatology (Oxford); 2017 Jun; 56(6):999-1007. PubMed ID: 28339994
[TBL] [Abstract][Full Text] [Related]
17. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
Rüegg CA; Maurer B; Laube I; Scholtze D
BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519721
[TBL] [Abstract][Full Text] [Related]
18. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
Szabó K; Nagy-Vincze M; Bodoki L; Hodosi K; Dankó K; Griger Z
Orv Hetil; 2016 Apr; 157(15):575-83. PubMed ID: 27039996
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
Phuong TNT; Ngoc LNT; Rönnelid J; Padyukov L; Lundberg IE
Int J Rheum Dis; 2021 May; 24(5):663-670. PubMed ID: 33788398
[TBL] [Abstract][Full Text] [Related]
20. Clinical heterogeneity and outcomes of antisynthetase syndrome.
Hervier B; Benveniste O
Curr Rheumatol Rep; 2013 Aug; 15(8):349. PubMed ID: 23794106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
